Country: Tanzania
Language: English
Source: Tanzania Medicinces & Medical Devices Authority
ARTEMETHER & LUMEFANTRINE TABLETS
Ajanta Pharma Limited, INDIA
Antimalarials
ARTEMETHER & LUMEFANTRINE TABLETS
60/360
Uncoated Tablets
AJANTA Pharma LIMITED, INDIA
Physical description: Yellow coloured, capsule shaped, biconvex uncoated tablets,with breakline on one side; Local technical representative: ASTRA PHARMA (T) Limited (4645)
Registered/Compliant
2022-04-11
TMDA/DMC/MRE/F/016 Version#1 TANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY PUBLIC ASSESSMENT REPORT FOR ARTEFAN 60/360 (ARTEMETHER 60 MG AND LUMEFANTRINE 360 MG) TABLETS VERSION NUMBER 1.0 14 APRIL, 2022 P. O. Box 77150, EPI Mabibo, Off Mandela Road, Dar es Salaam, Tanzania Tel: +255-22-2450512/2450751/ 2452108; Fax: +255-22-2450793 Email: info@tmda.go.tz; Website: mwww.tmda.go.tz 1. INTRODUCTION Artefan 60/360 is a generic medicine of innovator product Coartem® (Novartis Pharma, Switzerland). Artefan 60/360 contains a fixed combination of artemether and lumefantrine in the ratio of 1:6, which acts as an antimalarial against schizonts. Artemether is a semisynthetic chiral acetal derivative of artemisinin isolated from the plant Artemisia annua. Lumefantrine is a racemic mixture of a synthetic fluorene derivative. Like other antimalarials (quinine, mefloquine, halofantrine), lumefantrine belongs to the aryl-amino-alcohol family. Artefan 60/360 is approved in Tanzania for use in children who weigh between 25 kg to less than 35 kg. 1.1 PRODUCT DETAILS Registration number TAN 22 HM 0118 Brand name Artefan 60/360 Generic name, strength and form Each uncoated tablet containing 60 mg artemether and 360 mg lumefantrine ATC classification Artemisinin and derivatives, combinations (P01BF01) Distribution category POM Country of origin India Associated product Artefan 80/480, Artefan 20/120 Marketing Authorization Holder Ajanta Pharma Limited, Ajanta House, Charkop, Kandivli (West), Mumbai - 400 067, India. E-Mail: info@ajantapharma.com Local Technical Representative Astra Pharma (T) Ltd Plot no-12, Vingunguti Industrial Area, Nyerere Road, opp: Pepsi tanzania Ltd, Dar es Salaam, Tanzania 1.2 ASSESSMENT PROCEDURE The application for registration of Artefan 60/360 was submitted on 10 June, 2021. The product underwent abridged assessment. Assessment was completed in 2 (two) rounds of evaluation and the product was registered on 11 April, 2022. 1.3 INFORMATION FOR USERS Visual description of the finished product Yellow colo Read the complete document